![Xu Dong Yin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Dong Yin
Direttore/Membro del Consiglio presso LAEKNA, INC.
Profilo
Xu Dong Yin is currently a Director at Novartis New Zealand Ltd., NeuExCell Therapeutics, Inc., and Laekna, Inc. He previously worked as a Director Manager at Boston Consulting (Shanghai) Co. Ltd.
from 2000 to 2004, as the President-AstraZeneca China at AstraZeneca PLC from 2004 to 2011, and as the Head-Asia Pacific, Middle East & Africa Regions at Novartis Pharmaceuticals Corp.
from 2011 to 2021.
Dr. Yin holds an MBA from Harvard University, a doctorate from Stanford University, and an undergraduate degree from Peking University.
Posizioni attive di Xu Dong Yin
Società | Posizione | Inizio |
---|---|---|
LAEKNA, INC. | Direttore/Membro del Consiglio | - |
Novartis New Zealand Ltd.
![]() Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Direttore/Membro del Consiglio | - |
NeuExCell Therapeutics, Inc.
![]() NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Xu Dong Yin
Società | Posizione | Fine |
---|---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/12/2021 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2011 |
Boston Consulting (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01/02/2004 |
Formazione di Xu Dong Yin
Harvard University | Masters Business Admin |
Stanford University | Doctorate Degree |
Peking University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
LAEKNA, INC. | Health Technology |
Aziende private | 4 |
---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis New Zealand Ltd.
![]() Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Distribution Services |
NeuExCell Therapeutics, Inc.
![]() NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Health Services |
Boston Consulting (Shanghai) Co. Ltd. |
- Borsa valori
- Insiders
- Xu Dong Yin